Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 148 Results

Intervention Indication Therapeutic Area Year Actions
Retifanlimab for advanced/metastatic merkel cell carcinoma Retifanlimab (INCMGA00012; MGA-012) Merkel cell carcinoma (MCC) Skin Cancer 2021 View  |  Download
Ripretinib for gastrointestinal stromal tumour Ripretinib (DCC-2618; Quinlock) Gastrointestinal stromal tumour (GIST) Gastrointestinal Cancer 2021 View  |  Download
Risankizumab for moderate to severe crohn’s disease Risankizumab (BI 655066; Skyrizi; ABBV 066) Crohn's disease Gastroenterology , Immunology 2021 View  |  Download
Ritlecitinib for alopecia areata Ritlecitinib (PF-06651600) Alopecia areata Dermatology , Immunology 2021 View  |  Download
Ruxolitinib cream for vitiligo Ruxolitinib (Jakavi; INCB018424; CTP-543; ruxolitinib phosphate) Vitiligo Dermatology 2021 View  |  Download
Sabatolimab in addition to azacitidine for myelodysplastic syndromes – first-line Azacitidine (Vidaza; CC-486) , Sabatolimab (MBG453) Chronic myelomonocytic leukaemia (CMML) , Myelodysplastic syndrome (MDS) Haematological Cancer and Lymphomas 2021 View  |  Download
Sacituzumab govitecan for metastatic or unresectable locally advanced triple-negative breast cancer – third line Sacituzumab Govitecan (IMMU-132; Trodelvy) Breast cancer Breast Cancer 2021 View  |  Download
Sacituzumab govitecan for treating HR+/HER2- negative metastatic breast cancer Sacituzumab Govitecan (IMMU-132; Trodelvy) Breast cancer Breast Cancer 2021 View  |  Download
Sacubitril/valsartan for the treatment of post-acute myocardial infarction patients with left ventricular systolic dysfucntion and/or pulmonary congestion – first line Entresto; LCZ 696 (fixed dose combination: Sacubitril; Valsartan) Post-acute myocardial infarction (MI) Cardiovascular System 2021 View  |  Download
Secukinumab for hidradenitis suppurativa Secukinumab (Cosentyx; AIN457) Hidradenitis suppurativa (HS) Dermatology 2021 View  |  Download
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications